Showing results (71-80 of 431) with videos related to

Sort By:
Pageof 44
Oncology|October 2, 2008
Gender differences in treatment outcomes among patients with non-small cell lung cancer given a combination of carboplatin and paclitaxelHarukaze Yamamoto, Ikuo Sekine, Kazuhiko Yamada, et al.
Japanese Journal of Clinical Oncology|February 28, 2013
Renal toxicity caused by brand-name versus generic cisplatin: a comparative analysisSeiji Niho, Takeharu Yamanaka, Shigeki Umemura, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Change in the lymphocyte-to-monocyte ratio is an early surrogate marker of the efficacy of nivolumab monotherapy in advanced non-small-cell lung cancerKatsutoshi Sekine, Shintaro Kanda, Yasushi Goto, et al.
Advances in Therapy|May 31, 2020
Treatment Sequencing in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer in Japan: A Real-World Observational StudyYasushi Goto, Nobuyuki Yamamoto, Elizabeth T Masters, et al.
Virchows Archiv : an International Journal of Pathology|October 28, 2022
Insulinoma-associated-1 (INSM1) expression in thymic squamous cell carcinomaJumpei Kashima, Taiki Hashimoto, Akihiko Yoshida, et al.
Lung Cancer (Amsterdam, Netherlands)|June 8, 2020
Eltrombopag olamine for refractory immune-related thrombocytopenia induced by pembrolizumab in a non-small cell lung cancer patientMunehiro Ito, Shintaro Kanda, Tatsuya Yoshida, et al.
Histopathology|July 30, 2025
Dynamic nature of hepatic differentiation in lung adenocarcinomaChihiro Takemura, Satsuki Kishikawa, Jumpei Kashima, et al.
Japanese Journal of Clinical Oncology|April 19, 2017
Efficacy and safety of osimertinib in a Japanese compassionate use programYutaka Fujiwara, Yasushi Goto, Shintaro Kanda, et al.
Clinical Therapeutics|May 22, 2017
Systemic Treatment Patterns With Advanced or Recurrent Non-small Cell Lung Cancer in Japan: A Retrospective Hospital Administrative Database StudyFeng Wang, Sari Mishina, Shinji Takai, et al.
Investigational New Drugs|May 4, 2011
Safety and pharmacokinetic study of nab-paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small cell lung cancerIsamu Okamoto, Nobuyuki Yamamoto, Kaoru Kubota, et al.
Pageof 44